Cellosaurus cell line CM-2 [Human/mouse hybridoma] (CVCL

Cross-references
Cell line name	CM-2 [Human/mouse hybridoma]
Accession	CVCL_XI19
Resource Identification Initiative	To cite this cell line use: CM-2 [Human/mouse hybridoma] (RRID:CVCL_XI19)
Comments	Group: Patented cell line. Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2598. Monoclonal antibody isotype: IgM, lambda. Monoclonal antibody target: Human cancer cells.
Species of origin	Homo sapiens (Human) (NCBI Taxonomy: 9606) Mus musculus (Mouse) (NCBI Taxonomy: 10090)
Hierarchy	Parent: CVCL_9V19 (HAB-1)
Category	Hybridoma
Publications	PubMed=12775891; DOI=10.3233/HAB-2002-11401 Brandlein S.U., Lorenz J., Ruoff N., Hensel F., Beyer I., Muller J., Neukam K., Illert B., Eck M., Muller-Hermelink H.-K., Vollmers H.P. Human monoclonal IgM antibodies with apoptotic activity isolated from cancer patients. Hum. Antibodies 11:107-119(2002) Patent=WO2009104100A2 Vollmers H.P., Hensel F., Power B.E., Ilag L.L., Kelter A.-R., Schoenen F., Muller-Hermelink H.-K., Thalheimer A., Udabage L., Brandlein S.U. Antibody combinations, and methods of making and using same. Patent number WO2009104100A2, 27-Aug-2009 Patent=US7772372 Muller-Hermelink H.-K., Vollmers H.P. Neoplasm specific antibodies and uses thereof. Patent number US7772372, 10-Aug-2010
Encyclopedic resources	Wikidata; Q93455242
Entry history
Entry creation	19-Dec-2019
Last entry update	21-Mar-2023
Version number	4